{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-019005","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.329010+00:00","generated_at":"2026-05-21T07:42:21.515145+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"STRATA Skin Sciences Q1 2025 revenue $6.8M up 1%; net loss narrows to $2.4M","bullets":["Revenue $6.8M (+1% YoY); gross margin expanded 790 bps to 53.5%.","Net loss $2.4M (EPS -$0.58) vs $3.4M loss (-$0.96) in Q1 2024.","Adjusted EBITDA improved to -$0.55M from -$1.3M; operating expenses fell 5% to $5.7M.","International revenue grew 8% YoY, now 36% of total; DTC drove 32% more psoriasis patients.","Cash at quarter-end $7.8M; operating cash flow improved to -$0.55M."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-019005","json":"https://secwatch.observer/filing/0001140361-25-019005.json","markdown":"https://secwatch.observer/filing/0001140361-25-019005.md","text":"https://secwatch.observer/filing/0001140361-25-019005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/0001140361-25-019005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/ef20049049_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T07:42:21.515145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}